Single Agent Daratumumab in Advanced Multiple Myeloma Possesses Significant Efficacy Even in an Unselected "Real-World" Population

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia - Czech Republic
doi 10.5507/bp.2018.064
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Palacky University Olomouc

Related search

Daratumumab in Untreated Newly Diagnosed Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2019English

Real World Data of the Impact of First Cycle Daratumumab on Multiple Myeloma and AL Amyloidosis Services

British Journal of Haematology
Hematology
2017English

Efficacy of Single-Agent Bortezomib vs. Single-Agent Thalidomide in Patients With Relapsed or Refractory Multiple Myeloma: A Systematic Comparison

European Journal of Haematology
MedicineHematology
2007English

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory T(11;14) Multiple Myeloma

British Journal of Haematology
Hematology
2020English

Disseminated Cryptococcosis in a Patient With Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone

Internal Medicine
Internal MedicineMedicine
2019English

Daratumumab, Bortezomib and Dexamethasone (Dvd) vs Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (Rrmm): Efficacy and Safety Update (Castor)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Results of an Early Access Treatment Protocol of Daratumumab in United States Patients With Relapsed or Refractory Multiple Myeloma

Cancer
Cancer ResearchOncology
2018English

Daratumumab, Lenalidomide, and Dexamethasone (Drd) vs Lenalidomide and Dexamethasone (Rd) in Relapsed or Refractory Multiple Myeloma (Rrmm): Efficacy and Safety Update (Pollux)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses

Advances in Therapy
MedicinePharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy